School of Medicine
Showing 1-10 of 13 Results
-
Gary Dahl
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
-
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Current Research and Scholarly Interests As a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.
-
Kara Davis
Assistant Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Childhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
-
Patrick DeMoss
Affiliate, Dean's Office Operations - Dean Other
Current Research and Scholarly Interests I work in the Davis Lab trying to characterize the tumor microenvironment of Ewing Sarcoma, with an eventual goal to better understand immune interactions in hopes of improving immunotherapy for these tumors.
I am also interested in the history of medicine, specifically viewing current diseases through a historical prism, such as reading original accounts of diseases, laboratory results, and study protocols. Medicine is naturally a historical discipline: as knowledge accumulates, so medicine as a field progresses. Furthermore, by studying medicine in a historical context, I believe it enriches our current practice by connecting us with our predecessor physicians. -
Pablo Domizi, Ph.D.
Postdoctoral Research Fellow, Hematology-Oncology
Current Research and Scholarly Interests Understanding phenotypic flexibility in B-cell ALL and its impact on CAR-T therapy success. Integration of single cell RNA and protein expression data to build models to predict patients at risk of Antigen Loss relapse after CAR-T cell immunotherapies.
